C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 237/20 (2006.01) A61K 31/501 (2006.01) A61P 3/06 (2006.01) C07D 237/24 (2006.01)
Patent
CA 2533899
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I), where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
L'invention concerne des procédés de traitement d'une maladie ou d'une condition induite par SCD chez un mammifère, de préférence un être humain, ce procédé consistant à administrer à un mammifère le nécessitant un composé représenté par la formule (I). Dans cette formule x, y, W, V, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿, R?6a¿, R?7¿, R?7a¿, R?8¿, R?8a¿, R?9¿ et R?9a¿ y sont définis. L'invention concerne également des compositions pharmaceutiques comprenant les composés représentés par la formule (I).
Abreo Melwyn
Chafeev Mikhail
Chakka Nagasree
Chowdhury Sultan
Fu Jian-Min
Smart & Biggar
Xenon Pharmaceuticals Inc.
LandOfFree
Pyridazine derivatives and their use as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridazine derivatives and their use as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridazine derivatives and their use as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1355650